Search the Site

Twitter

test tubes

You are here: Home » Articles » BioAlgoTrades

BioAlgoTrades

publication date: Mar 11, 2017
 | 
author/source: Mike Havrilla



BioAlgoTrades
 is a real-time quantitative systematic algorithmic trading alerts system that is provided as a monthly subscription service. The service uses a private twitter feed to provide subscribers with opening and closing trade alerts for high volume exchange-traded funds (ETFs) and stocks in the healthcare sector. The system is based on a quantitative systematic digital signal processing algorithm that is designed to capture directional movement (aka momentum) and is illustred graphically in the above image. The system performs best when the underlying ETFs and stocks move directionally and will not perform well when these tickers are in a sideways or trendless pattern.

 

Based on our experience to date, alerts may remain open anywhere from days to weeks or even months depending on market conditions, which also impacts the frequency and volume of alerts being generated. The alert signals typically occur every morning as an open-to-open system; which means the alerts will usually be posted shortly after the market open by a member of the system's development team. The system provides an alert signal for entry and a signal for exiting a position (e.g. buy/long alert, sell/close long alert, short sell/open alert, cover short/close alert). Subscribers must consider their own risk tolerance and management, which can be complemented by the system--e.g. if there is a gain on a trade alert, then subscribers may choose to close the position and book the gain before the system generates a formal exit alert for the trade.

 

Below is a summary of year-to-date performance stats and alerts. On 3/7/17, the system went from long to short after booking large gains across the board for the recent upside move in the biopharma industry and overall healthcare sector. While the downside call has yet to be in the money; the system tends to detect moves early so alerts may be in the negative for several days before turning positive. As seen in the year-to-date alerts below; the system works best for directional markets so the recent run-up in the healthcare sector and especially in the biopharma industry resulted in solid gains across the board so if there is a pullback in the near-term; the current alerts will likely generate similar returns. However, if there is sideways trading action to consolidate recent gains or if the upside momentum continues; then the recent round of short alerts will remain in the negative or possibly be closed out or reversed back to long alerts. 

 

1/26/17 BIOALGO ALERTS:  $ACAD: Long @ 31.56, $XBI: Long @ 63.45, $LABU: Long @ 37.84 ,$LABD: Short @ 14.73, $BIS: Short @ 32.18, $XPH: Long @ 38.10, $IBB: Long @ 274.78, $BIB: Long @ 42.71

 

2/10/17 BIOALGO ALERT:  $ACAD: Sell Alert @ 37.45 (+18.7% on closed long alert)

 

2/14/17 BIOALGO ALERT:  $ACAD Short Alert @ 37.20

 

3/7/17 BIOALGO ALERTS:  $XBI: Sell & Short Alert @ 69.90 (+10.2% on closed long alert), $LABU: Sell & Short Alert @ 49.41 (+30.6% on closed long alert),  $LABD: Buy Alert @ 10.57 (+28.2% on closed short alert), $XPH: Short Alert @ 40.87 (+7.3% on closed long alert) , $IHI: Short Alert @ 149.50, $CURE: Short Alert @ 35.17, $BIS: Long Alert @ 27.65 (+14% on closed short alert), $BIB: Short Alert @ 49.03 (+14.8% on closed long alert)


OPEN BIOALGO ALERTS AS OF MARKET CLOSE ON 3/10:  $ACAD short alert @$37.20 ($36.83 as of 3/10 market close +1%), $XBI short alert @$69.90 ($71.50 as of 3/10 market close -2.3%), $LABU short alert @$49.41 ($52.95 as of 3/10 market close -7.2%), $LABD buy alert @$10.57 ($9.81 as of 3/11 market close -7.2%), $IHI short alert @$149.50 ($151.51 as of 3/10 market close -1.3%), $CURE short alert @$35.17 ($36.60 as of 3/11 market close -4.1%), $BIS long alert @$27.65 ($26.67 as of 3/10 market close -3.7%), $BIB short alert @$49.03 ($50.78 as of 3/10 market close -3.6%)

 

We are offering the new service in partnership with the developers of this proprietary system as its first application in the healthcare sector. Because the system is applied for professional trading applications outside of the health care sector; the developers cannot disclose any details beyond what is described here due to financial regulations. Algo-based trading systems are increasingly being used by hedge funds and other automated trading systems that are typically limited to high net worth investors; so our goal is to level the playing field in the health care sector by offering the service outside of these restricted investment vehicles.

 

The monthly subscription rate is $59.97 and includes a one-time free trial period of one week (see instructions below for details on the cancellation process through PayPal). If you are a current BioRunUp subscriber, click here to view your promo rate which includes a 2-week free trial period.

 

 

To request access to @BioAlgoTrades, you MUST do the following, in this EXACT order:

1.) You must have a Twitter Account

 2.) Send an email to bioalgotrades@gmail.com to provide us with your Twitter username and the email address you used to subscribe to BioAlgoTrades (for verification purposes). Also use this email for any BioAlgoTrades service related inquiries.

 3. From your Twitter account visit @BioAlgoTrades and request to follow the private feed. We will then verify your email address / Twitter ID / BioAlgoTrades account request and approve for access to the private Twitter feed within one business day. 

 

How to cancel an automatic payment (monthly subscription) via PayPal:

 1.) Log in to your PayPal account.

 2.) Click Profile at the top of the page.

 3.) Click My Money, then click Update beside My pre-approved payments to find your payment.

4.) Select the payment, and then click Cancel.

 

Please refer to the terms and conditions for additional disclaimers for this service which is offered by BioRunUp, LLC, which are in addition to specific risk factors outlined above. Since we offer a one-time free trial and there is only a monthly subscription option at this time; no refunds will be issued for this service.